Sort   by:  
 Page size 
The resistance of cancer cell to therapy is responsible of the death of most cancer patients. Epithelial to mesenchymal transitions (EMT) has been associated with resistance to therapy in different cancer cells. However, the mechanisms by which EMT mediates resistance to therapy remain poorly unders...
ORGANISM(S): Mus musculus (Mouse) 
2023-01-13 | PXD025737 | Pride
The resistance of cancer cells to therapy is responsible for the death of most cancer patients. Epithelial-to-mesenchymal transition (EMT) has been associated with resistance to therapy in different cancer cells. However, the mechanisms by which EMT mediates resistance to therapy remain poorly under...
ORGANISM(S): Mus musculus (Mouse) 
2023-01-13 | PXD038278 | Pride
RhoJ controls EMT associated resistance to chemotherapy
To identify potential mechanisms by which EMT tumour cells are resistant to chemotherapy, we assessed the expression of putative mediators of resistance to therapy in Epcam+ and Epcam- tumour cells from skin squamous cell carcinoma. To determine how RhoJ impacts the transcriptional landscape of Epca...
ORGANISM(S): Mus musculus 
2023-01-13 | GSE205985 | GEO
Genes and pathways that allow cells to cope with oncogene-induced stress represent selective cancer therapeutic targets that remain largely undiscovered. In this study, we identify a RhoJ signaling pathway that is a selective therapeutic target for BRAF mutant cells. RhoJ deletion in BRAF mutant mel...
ORGANISM(S): Mus musculus 
2017-07-26 | GSE101859 | GEO
Sort   by:  
 Page size